How an $84,000 drug got its price: 'Let's hold our position … whatever the headlines' - The Washington Post
Gilead launches combination HIV pill in UK and Germany - PMLiVE
U.K. marketing police slam Gilead for claiming Biktarvy tolerability beats GSK rival | Fierce Pharma
Trump administration sues Gilead over HIV drugs
Gilead reaches multiyear agreement with White House to donate PrEP
Gilead Sciences, Inc.
Gilead's Veklury expands FDA nod to patients outside the hospital as oral version heads to trial | Fierce Pharma
FDA grants EUA for Gilead's remdesivir to treat Covid-19 - Pharmaceutical Technology
Gilead Advancing Access®: What to Know | Prism Health North Texas
Gilead drug shows positive signs in early coronavirus testing | Financial Times
AHF • AHF Calls on Gilead to Set Up $10 Billion Fund for Victims Harmed by its TDF-based Drugs
Generic HIV prevention drug coming in 2020, Gilead says
Gilead says generic Truvada will be available in 2020
Gilead Grants $24M to Improve Access, Care for HIV Communities
Top Research Reports for JPMorgan, Gilead Sciences & CSX
Gilead reports 3% revenue growth in Q1 2022
Single patient study adds to debate over Gilead's remdesivir for COVID-19 | Reuters
Gilead Assistance Programs For HIV, Hep B Drugs Will Dial Back Reimbursement To 340B Providers :: Pink Sheet
Change to Gilead assistance program threatens PrEP access, HIV advocates say | PBS NewsHour
PrEP's Still Too Costly For Many People At Risk For HIV : Shots - Health News : NPR
Change to Gilead Assistance Program Threatens PrEP Access, HIV Advocates Say | Kaiser Health News
Gilead to Slice List Prices of Liver Drugs - WSJ
Gilead says counterfeiters sold $250M worth of fake HIV drugs, sues distributors | Fierce Pharma
Gilead Will Donate Truvada to U.S. for H.I.V. Prevention - The New York Times
Gilead prices remdesivir at $2,340 per patient for developed countries
Appeal lodged against decision to uphold Gilead's patent on hepatitis C drug | MSF
Untangling the Trump administration's lawsuit over an HIV prevention drug | Science | AAAS
Patients sue Gilead, saying drug company intentionally delayed safer HIV medicine - Los Angeles Times
